Misplaced Pages

Schering-Plough: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 14:29, 30 May 2009 editMbernste (talk | contribs)219 edits →History← Previous edit Revision as of 17:01, 8 June 2009 edit undoDarkfrog24 (talk | contribs)Autopatrolled, Extended confirmed users16,795 edits →History: refs with periods, italics, hyphens, consistent use of serial comma and quote marks with other punctNext edit →
Line 31: Line 31:
Following the entry of the ] into ] in 1941, U.S. President ] ordered ]'s U.S. assets be seized. These became the Schering Corporation. The company was placed under a government administratorship until 1952, when it was released and its assets sold to the private sector. Following the entry of the ] into ] in 1941, U.S. President ] ordered ]'s U.S. assets be seized. These became the Schering Corporation. The company was placed under a government administratorship until 1952, when it was released and its assets sold to the private sector.


Plough, Incorporated was founded by the ] area entrepreneur Abe Plough in 1908 . He borrowed $125 from his father to start the business at age 16. As a one man business, he mixed "Plough's Antiseptic Healing Oil," a "sure cure for any ill of man or beast," and sold it off a horse drawn buggy <ref></ref>. He grew the company through sound management and innovative strategies, with marketing genius. Plough, Incorporated was founded by the ] area entrepreneur Abe Plough in 1908 . He borrowed $125 from his father to start the business at age sixteen. As a one man business, he mixed "Plough's Antiseptic Healing Oil," a "sure cure for any ill of man or beast," and sold it off a horse-drawn buggy.<ref></ref> He grew the company through sound management and innovative strategies, with marketing genius.{{Fact|reason=Please give a source for this assertion. It's not in keeping with neutral POV|date=June 2009}}


Plough's acquisitions included St Joseph's Aspirin for children <ref></ref>, ] cosmetics, and ] skin care products. Plough also had a broadcasting division, operating radio stations in ]; ]; ], ], and ]. Plough's acquisitions included St Joseph's Aspirin for children,<ref></ref> ] cosmetics, and ] skin care products. Plough also had a broadcasting division, operating radio stations in ]; ]; ]; ]; and ].


In 1971, the Schering Corporation merged with Plough, Inc. At the time of the merger, Abe Plough became Chairman of the combined company <ref></ref>. In 1971, the Schering Corporation merged with Plough, Inc. At the time of the merger, Abe Plough became Chairman of the combined company.<ref></ref>


In 2000, Schering Plough bought a new campus in ] from ]. The company planned to make this location its second largest corporate complex in the world after completion of its current $20 million renovation. In 2000, Schering Plough bought a new campus in ] from ]. The company planned to make this location its second-largest corporate complex in the world after completion of its current $20 million renovation.


Schering-Plough was named one of the 100 Best Companies for Working Mothers in 2004 and 2005 by ''Working Mothers'' magazine. Schering-Plough was named one of the ''100 Best Companies for Working Mothers'' in 2004 and 2005 by ''Working Mothers'' magazine.


One of Schering-Plough's plants, in ] is the largest single site for the production of veterinary ] in the world.{{Fact|date=November 2007}} This is largely due to the fact that ]'s isolation has formed a natural ] and is free of ], ], ], ] and many other livestock diseases. It formerly had ], but this has been eradicated. The site is known locally as "Coopers Animal Health," a trademark still in use by Schering-Plough in Australia, but not elsewhere. One of Schering-Plough's plants, in ] is the largest single site for the production of veterinary ] in the world.{{Fact|date=November 2007}} This is largely due to the fact that ]'s isolation has formed a natural ], leaving the country free of ], ], ], ], and many other livestock diseases. It formerly had ], but this has been eradicated. The site is known locally as "Coopers Animal Health," a trademark still in use by Schering-Plough in Australia, but not elsewhere.


In March 2007, Schering-Plough Corp. purchased ], the drug unit of Netherlands-based Akzo Nobel, for $14.4 billion, giving the US pharmaceutical company an array of women's health products and numerous late-stage pipelines of experimental medicines. In March 2007, Schering-Plough Corp. purchased ], the drug unit of Netherlands-based Akzo Nobel, for $14.4 billion, giving the US pharmaceutical company an array of women's health products and numerous late-stage pipelines of experimental medicines.
Line 50: Line 50:
As a result of the acquisition of Organon, Schering-Plough bolstered its animal health business with the Akzo subsidiary Intervet and gained access to human vaccine production through the subsidiary Nobilon. As a result of the acquisition of Organon, Schering-Plough bolstered its animal health business with the Akzo subsidiary Intervet and gained access to human vaccine production through the subsidiary Nobilon.


On March 9, 2009 it was announced that Schering-Plough was to merge with ] and through a ] have Merck be a subsidiary of Schering-Plough who will rename itself Merck. <ref></ref>. On March 9, 2009 it was announced that Schering-Plough was to merge with ] and through a ] have Merck be a subsidiary of Schering-Plough, which will rename itself Merck.<ref></ref>


==Medical products== ==Medical products==

Revision as of 17:01, 8 June 2009

This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (November 2007) (Learn how and when to remove this message)
Schering-Plough Corporation
Company typePublic (NYSE: SGP)
IndustryPharmaceuticals
Founded1971 (by merger with Plough, Inc.)
HeadquartersKenilworth, New Jersey
Key peopleFred Hassan, CEO & Chairman
ProductsRemicade, Levitra, Zetia, Vytorin, Nasonex, Asmanex , Claritin, Aerius, Afrin, Nuvaring, Home Again Pet Recovery System, Banamine, Clarinex, Dr Scholl's, Coppertone, Famvir
RevenueUS$ 18.502 billion (2008)
Net incomeUS$ 1.903 billion (2008)
Number of employees50,000
Websitehttp://www.schering-plough.com/

Schering-Plough Corporation (NYSE: SGP) is a pharmaceutical company founded in 1851 by Ernst Schering as Schering AG in Germany. In 1971, the Schering Corporation merged with Plough (founded by Memphis area entrepreneur Abe Plough in 1908 ) to form Schering Plough.

Schering Plough manufactures several pharmaceutical drugs, the most well-known of which are the allergy drugs Claritin and Clarinex, and through a collaboration with Merck & Co., Vytorin, an anti-cholesterol drug.

Schering Plough also owns and operates the major foot care brand name Dr. Scholl's and the skin care line Coppertone.

As of June 2005, Schering-Plough had 1.4% market share in the U.S., placing it at #17 in the top 20 pharmaceutical corporations by sales compiled by IMS Health.

Schering-Plough is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

History

Schering was founded in 1851 by Ernst Schering as Schering AG in Germany.

Following the entry of the United States into World War II in 1941, U.S. President Franklin Delano Roosevelt ordered Schering AG's U.S. assets be seized. These became the Schering Corporation. The company was placed under a government administratorship until 1952, when it was released and its assets sold to the private sector.

Plough, Incorporated was founded by the Memphis, Tennessee area entrepreneur Abe Plough in 1908 . He borrowed $125 from his father to start the business at age sixteen. As a one man business, he mixed "Plough's Antiseptic Healing Oil," a "sure cure for any ill of man or beast," and sold it off a horse-drawn buggy. He grew the company through sound management and innovative strategies, with marketing genius.

Plough's acquisitions included St Joseph's Aspirin for children, Maybelline cosmetics, and Coppertone skin care products. Plough also had a broadcasting division, operating radio stations in Atlanta, Georgia; Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois; and Memphis, Tennessee.

In 1971, the Schering Corporation merged with Plough, Inc. At the time of the merger, Abe Plough became Chairman of the combined company.

In 2000, Schering Plough bought a new campus in Summit, New Jersey from Novartis. The company planned to make this location its second-largest corporate complex in the world after completion of its current $20 million renovation.

Schering-Plough was named one of the 100 Best Companies for Working Mothers in 2004 and 2005 by Working Mothers magazine.

One of Schering-Plough's plants, in Upper Hutt, New Zealand is the largest single site for the production of veterinary vaccines in the world. This is largely due to the fact that New Zealand's isolation has formed a natural quarantine, leaving the country free of rabies, foot and mouth, scrapie, bovine spongiform encephalopathy, and many other livestock diseases. It formerly had echinococcosis, but this has been eradicated. The site is known locally as "Coopers Animal Health," a trademark still in use by Schering-Plough in Australia, but not elsewhere.

In March 2007, Schering-Plough Corp. purchased Organon International, the drug unit of Netherlands-based Akzo Nobel, for $14.4 billion, giving the US pharmaceutical company an array of women's health products and numerous late-stage pipelines of experimental medicines.

Organon was founded in 1923 by Dr. Saal van Zwanenberg, the president of Zwanenberg’s Slachterijen en Fabrieken. The company is housed at Zwanenberg’s premises in Oss, the Netherlands. By August 21,2008, Famvir (famciclovir) was marketed as Schering-Plough; formerly it was marketed by Novartis.

As a result of the acquisition of Organon, Schering-Plough bolstered its animal health business with the Akzo subsidiary Intervet and gained access to human vaccine production through the subsidiary Nobilon.

On March 9, 2009 it was announced that Schering-Plough was to merge with Merck & Co. and through a reverse takeover have Merck be a subsidiary of Schering-Plough, which will rename itself Merck.

Medical products

Prescription products

Over-the-counter products

Veterinary products

Exercise drug

Schering-Plough has received recent publicity for a new drug AICAR which mimics the effects of exercise, having especially potent effects when used alongside another drug GW1516 developed by GlaxoSmithKline.

Collaborative research

In addition to internal research and development activities Schering-Plough is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox.

Controversy

In 2004, Schering-Plough was accused of marketing gimmicks and payoffs to doctors for prescribing the company's pharmaceutical products .

Schering-Plough entered into a Consent Decree with the FDA on March 6th 2002 due to manufacturing issues with its albuterol inhaler. It was ordered to pay $500 Million USD as follows; Schering-Plough Corporation agrees to pay one hundred seventy-five million dollars ($175,000,000.00) to the United States Treasury no later than ten (10) days after the date of entry of this Decree. Schering-Plough Products, LLC agrees to pay seventy-five million dollars ($75,000,000.00) to the United States Treasury no later than ten (10) days after the date of entry of this Decree. With respect to the remaining two hundred and fifty million dollars ($250,000,000.00), one hundred seventy-five million dollars ($175,000,000.00) shall be paid by Schering-Plough Corporation and seventy-five million dollars ($75,000,000.00) shall be paid by Schering-Plough Products, LLC, to the United States Treasury no later than three hundred sixty-five (365) days after the date of entry of this Decree.

It was also ordered to complete a rigorous series of inspections by a 3rd party inspector, in this case LCS, by 2006.

Notes

  1. "Abe Plough (1892-1984)", Tennessee Encyclopedia of History and Culture, on line.
  2. "The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). p. 49. Retrieved 2008-08-25.
  3. "Abe Plough (1892-1984)," Tennessee Encyclopedia of History and Culture, on line.
  4. "Abe Plough (1892-1984)", Tennessee Encyclopedia of History and Culture, on line.
  5. Hoover's Profile: Schering-Plough Corporation
  6. Natasha Singer, "Merck to Buy Schering-Plough for $41.1 Billion", New York Times (March 9, 2009).
  7. Gupta SK, Ellinwood EH (1988). "Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam" (PDF). Pharm. Res. 5 (6): 365–8. PMID 3244647. {{cite journal}}: Unknown parameter |month= ignored (help)
  8. Mattes WB (2008), Public consortium efforts in toxicogenomics, Methods Mol Biol. 2008;460:221-38
  9. "InnoMed PredTox Member Organizations". Retrieved 2008-08-25.
  10. Gardiner Harris, "As Doctors Write Prescriptions, Drug Company Writes a Check", New York Times (June 27, 2004)

References

External links

Categories: